View in EDS PDF Full Text

Atovaquone for treatment of COVID-19: A prospective randomized, double-blind, placebo-controlled clinical trial.

Saved in:
Bibliographic Details
Title: Atovaquone for treatment of COVID-19: A prospective randomized, double-blind, placebo-controlled clinical trial.
Authors: Jain MK; Department of Internal Medicine/Infectious Diseases, University of Texas Southwestern Medical Center, Dallas, TX, United States.; Parkland Health and Hospital System, Dallas, TX, United States., De Lemos JA; Parkland Health and Hospital System, Dallas, TX, United States.; Department of Internal Medicine/Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, United States., McGuire DK; Parkland Health and Hospital System, Dallas, TX, United States.; Department of Internal Medicine/Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Ayers C; Department of Internal Medicine/Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Eitson JL; Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Sanchez CL; Department of Internal Medicine/Infectious Diseases, University of Texas Southwestern Medical Center, Dallas, TX, United States., Kamel D; Department of Internal Medicine/Infectious Diseases, University of Texas Southwestern Medical Center, Dallas, TX, United States., Meisner JA; Department of Internal Medicine/Infectious Diseases, University of Pennsylvania, Philadelphia, PA, United States., Thomas EV; Department of Internal Medicine/Hospital Medicine, University of Texas Southwestern Medical Center, Dallas, TX, United States., Hegde AA; Parkland Health and Hospital System, Dallas, TX, United States.; Department of Internal Medicine/Hospital Medicine, University of Texas Southwestern Medical Center, Dallas, TX, United States., Mocherla S; Department of Internal Medicine/Infectious Diseases, University of Texas Southwestern Medical Center, Dallas, TX, United States.; Parkland Health and Hospital System, Dallas, TX, United States., Strebe JK; Parkland Health and Hospital System, Dallas, TX, United States., Li X; Department of Population and Data Science, University of Texas Southwestern Medical Center, Dallas, TX, United States., Williams NS; Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX, United States., Xing C; McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, TX, United States., Ahmed MS; Department of Internal Medicine/Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Wang P; Department of Internal Medicine/Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Sadek HA; Department of Internal Medicine/Infectious Diseases, University of Texas Southwestern Medical Center, Dallas, TX, United States.; Departments Biophysics, and Molecular Biology, and Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX, United States., Schoggins JW; Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Source: Frontiers in pharmacology [Front Pharmacol] 2022 Sep 30; Vol. 13, pp. 1020123. Date of Electronic Publication: 2022 Sep 30 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36249792
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Atovaquone for treatment of COVID-19: A prospective randomized, double-blind, placebo-controlled clinical trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jain+MK%22">Jain MK</searchLink>; Department of Internal Medicine/Infectious Diseases, University of Texas Southwestern Medical Center, Dallas, TX, United States.; Parkland Health and Hospital System, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22De+Lemos+JA%22">De Lemos JA</searchLink>; Parkland Health and Hospital System, Dallas, TX, United States.; Department of Internal Medicine/Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22McGuire+DK%22">McGuire DK</searchLink>; Parkland Health and Hospital System, Dallas, TX, United States.; Department of Internal Medicine/Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Ayers+C%22">Ayers C</searchLink>; Department of Internal Medicine/Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Eitson+JL%22">Eitson JL</searchLink>; Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Sanchez+CL%22">Sanchez CL</searchLink>; Department of Internal Medicine/Infectious Diseases, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Kamel+D%22">Kamel D</searchLink>; Department of Internal Medicine/Infectious Diseases, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Meisner+JA%22">Meisner JA</searchLink>; Department of Internal Medicine/Infectious Diseases, University of Pennsylvania, Philadelphia, PA, United States.<br /><searchLink fieldCode="AU" term="%22Thomas+EV%22">Thomas EV</searchLink>; Department of Internal Medicine/Hospital Medicine, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Hegde+AA%22">Hegde AA</searchLink>; Parkland Health and Hospital System, Dallas, TX, United States.; Department of Internal Medicine/Hospital Medicine, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Mocherla+S%22">Mocherla S</searchLink>; Department of Internal Medicine/Infectious Diseases, University of Texas Southwestern Medical Center, Dallas, TX, United States.; Parkland Health and Hospital System, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Strebe+JK%22">Strebe JK</searchLink>; Parkland Health and Hospital System, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Li+X%22">Li X</searchLink>; Department of Population and Data Science, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Williams+NS%22">Williams NS</searchLink>; Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Xing+C%22">Xing C</searchLink>; McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Ahmed+MS%22">Ahmed MS</searchLink>; Department of Internal Medicine/Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Wang+P%22">Wang P</searchLink>; Department of Internal Medicine/Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Sadek+HA%22">Sadek HA</searchLink>; Department of Internal Medicine/Infectious Diseases, University of Texas Southwestern Medical Center, Dallas, TX, United States.; Departments Biophysics, and Molecular Biology, and Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Schoggins+JW%22">Schoggins JW</searchLink>; Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2022 Sep 30; Vol. 13, pp. 1020123. <i>Date of Electronic Publication: </i>2022 Sep 30 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36249792
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2022.1020123
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1020123
    Titles:
      – TitleFull: Atovaquone for treatment of COVID-19: A prospective randomized, double-blind, placebo-controlled clinical trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jain MK
      – PersonEntity:
          Name:
            NameFull: De Lemos JA
      – PersonEntity:
          Name:
            NameFull: McGuire DK
      – PersonEntity:
          Name:
            NameFull: Ayers C
      – PersonEntity:
          Name:
            NameFull: Eitson JL
      – PersonEntity:
          Name:
            NameFull: Sanchez CL
      – PersonEntity:
          Name:
            NameFull: Kamel D
      – PersonEntity:
          Name:
            NameFull: Meisner JA
      – PersonEntity:
          Name:
            NameFull: Thomas EV
      – PersonEntity:
          Name:
            NameFull: Hegde AA
      – PersonEntity:
          Name:
            NameFull: Mocherla S
      – PersonEntity:
          Name:
            NameFull: Strebe JK
      – PersonEntity:
          Name:
            NameFull: Li X
      – PersonEntity:
          Name:
            NameFull: Williams NS
      – PersonEntity:
          Name:
            NameFull: Xing C
      – PersonEntity:
          Name:
            NameFull: Ahmed MS
      – PersonEntity:
          Name:
            NameFull: Wang P
      – PersonEntity:
          Name:
            NameFull: Sadek HA
      – PersonEntity:
          Name:
            NameFull: Schoggins JW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 09
              Text: 2022 Sep 30
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 1663-9812
          Numbering:
            – Type: volume
              Value: 13
          Titles:
            – TitleFull: Frontiers in pharmacology
              Type: main
ResultId 1